/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Mangoceuticals Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$1.18 0.0603(6.03%) MGRX at 04 Dec 2025 04:38 PM Health Information Services
Lowest Today 1.12
Highest Today 1.24
Today’s Open 1.16
Prev. Close 1.16
52 Week High 6.15
52 Week Low 0.98
Day’s Range: Low 1.12 High 1.24
52-Week Range: Low 0.98 High 6.15
1 day return -
1 Week return +13.3
1 month return -30.22
3 month return -39.16
6 month return -42.42
1 year return -50.79
3 year return -
5 year return -
10 year return -

Institutional Holdings

Market Status

Fundamentals

Market Cap 16.13 M

PB Ratio 0.9814

PE Ratio 0.0

Enterprise Value 15.07 M

Total Assets 15.37 M

Volume 373497

Company Financials

Annual Revenue FY23:496058 0.5M, FY22:8939 0.0M

Annual Profit FY23:293768 0.3M, FY22:4850 0.0M

Annual Net worth FY23:-7318025 -7.3M, FY22:-1998055 -2.0M

Quarterly Revenue Q3/2025:84246 0.1M, Q2/2025:168109 0.2M, Q1/2025:109306 0.1M, Q3/2024:133368 0.1M, Q2/2024:163163 0.2M

Quarterly Profit Q3/2025:50899 0.1M, Q2/2025:89948 0.1M, Q1/2025:62064 0.1M, Q3/2024:82671 0.1M, Q2/2024:69792 0.1M

Quarterly Net worth Q3/2025:-7618218 -7.6M, Q2/2025:-5415818 -5.4M, Q1/2025:-4839391 -4.8M, Q3/2024:-1999694 -2.0M, Q2/2024:-2390979 -2.4M

Fund house & investment objective

Company Information Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. The company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

Organisation Health Information Services

Employees 3

Industry Health Information Services

CEO Mr. Jacob D. Cohen

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow